drugset / Trial / NCT00036218
Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease.
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary purpose of this study is to determine whether sumanirole is effective and safe in the treatment of the signs and symptoms of early Parkinson's disease.
Timeline
- Start
- 2001-12
- Primary completion
- —
- Completion
- 2003-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ropinirole | Small molecule | — | — |
| Subject | sumanirole | Small molecule | — | — |